Free Trial

Victory Capital Management Inc. Trims Position in Genpact Limited (NYSE:G)

Genpact logo with Computer and Technology background

Victory Capital Management Inc. reduced its stake in shares of Genpact Limited (NYSE:G - Free Report) by 1.6% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 9,692,244 shares of the business services provider's stock after selling 161,193 shares during the quarter. Genpact makes up approximately 0.5% of Victory Capital Management Inc.'s investment portfolio, making the stock its 25th largest position. Victory Capital Management Inc. owned approximately 5.52% of Genpact worth $488,295,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also recently made changes to their positions in G. Coppell Advisory Solutions LLC boosted its stake in shares of Genpact by 529.5% during the fourth quarter. Coppell Advisory Solutions LLC now owns 598 shares of the business services provider's stock valued at $25,000 after purchasing an additional 503 shares during the period. Atlas Capital Advisors Inc. boosted its stake in shares of Genpact by 55.8% during the fourth quarter. Atlas Capital Advisors Inc. now owns 603 shares of the business services provider's stock valued at $26,000 after purchasing an additional 216 shares during the period. Cornerstone Planning Group LLC purchased a new stake in Genpact in the first quarter worth about $27,000. GeoWealth Management LLC lifted its stake in Genpact by 199.0% in the fourth quarter. GeoWealth Management LLC now owns 876 shares of the business services provider's stock worth $38,000 after acquiring an additional 583 shares during the period. Finally, Global X Japan Co. Ltd. purchased a new stake in Genpact in the first quarter worth about $57,000. 96.03% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other Genpact news, Director Nicholas C. Gangestad bought 2,000 shares of the firm's stock in a transaction dated Tuesday, May 13th. The shares were purchased at an average price of $43.97 per share, for a total transaction of $87,940.00. Following the transaction, the director directly owned 2,000 shares of the company's stock, valued at approximately $87,940. This represents a ∞ increase in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 3.07% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on G. Mizuho upped their price objective on shares of Genpact from $48.00 to $51.00 and gave the stock a "neutral" rating in a research note on Tuesday, July 1st. Deutsche Bank Aktiengesellschaft began coverage on shares of Genpact in a research note on Thursday. They issued a "hold" rating and a $47.00 price objective for the company. Robert W. Baird lowered their price objective on shares of Genpact from $56.00 to $50.00 and set a "neutral" rating for the company in a research note on Thursday, May 8th. Needham & Company LLC reiterated a "buy" rating and issued a $50.00 target price on shares of Genpact in a report on Monday, June 30th. Finally, Wall Street Zen upgraded shares of Genpact from a "buy" rating to a "strong-buy" rating in a report on Friday, June 6th. Five investment analysts have rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $49.75.

Check Out Our Latest Research Report on Genpact

Genpact Stock Performance

NYSE:G traded down $0.09 during midday trading on Friday, hitting $45.37. The company's stock had a trading volume of 792,344 shares, compared to its average volume of 1,424,517. Genpact Limited has a fifty-two week low of $32.18 and a fifty-two week high of $56.76. The firm's 50 day moving average is $43.75 and its 200-day moving average is $47.13. The company has a debt-to-equity ratio of 0.48, a current ratio of 2.45 and a quick ratio of 2.45. The firm has a market cap of $7.93 billion, a P/E ratio of 15.48, a P/E/G ratio of 1.98 and a beta of 0.94.

Genpact (NYSE:G - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The business services provider reported $0.84 earnings per share for the quarter, topping the consensus estimate of $0.80 by $0.04. The company had revenue of $1.21 billion for the quarter, compared to the consensus estimate of $1.21 billion. Genpact had a net margin of 10.88% and a return on equity of 22.35%. Genpact's quarterly revenue was up 7.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.73 EPS. Equities analysts anticipate that Genpact Limited will post 3.21 earnings per share for the current fiscal year.

Genpact Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, September 25th. Stockholders of record on Thursday, September 11th will be given a dividend of $0.17 per share. The ex-dividend date is Thursday, September 11th. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.50%. Genpact's dividend payout ratio (DPR) is 23.21%.

About Genpact

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Recommended Stories

Institutional Ownership by Quarter for Genpact (NYSE:G)

Should You Invest $1,000 in Genpact Right Now?

Before you consider Genpact, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.

While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Set to Soar in Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

7 Nuclear Stocks One Announcement Away from Exploding
Goldman Sachs Warns of 20% Market Drop—Are They Right?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines